Patents by Inventor Namritha Ravinder

Namritha Ravinder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRISPR OLIGONCLEOTIDES AND GENE EDITING
    Publication number: 20220033858
    Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
    Type: Application
    Filed: May 21, 2021
    Publication date: February 3, 2022
    Inventors: Namritha RAVINDER, Korbinian HEIL, Yizhu GUO, Xiquan LIANG, Robert POTTER, Sanjay KUMAR
  • COMPOSITIONS AND METHODS FOR ENHANCING HOMOLOGOUS RECOMBINATION
    Publication number: 20200080077
    Abstract: The present disclosure generally relates to compositions and methods for improving the efficiency of homologous recombination. In particular, the disclosure relates to reagents and the use of such reagents.
    Type: Application
    Filed: August 9, 2019
    Publication date: March 12, 2020
    Inventors: Xiquan LIANG, Robert POTTER, Namritha RAVINDER, Shantanu KUMAR
  • Compositions and methods for enhancing homologous recombination
    Patent number: 10428327
    Abstract: The present disclosure generally relates to compositions and methods for improving the efficiency of homologous recombination. In particular, the disclosure relates to reagents and the use of such reagents.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: October 1, 2019
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Xiquan Liang, Robert Potter, Namritha Ravinder
  • STABILIZED REAGENTS FOR GENOME MODIFICATION
    Publication number: 20180327738
    Abstract: The present disclosure generally relates to compositions and methods for genetic modification of cells. In particular, the disclosure relates to stabilized reagents for genome alteration (e.g., site specific nucleases), as well as stabilized reagents for non-genetic code altering modification (e.g., DNA methylation). Stabilization methods include storage of reagents at suitable temperatures, conversion to dry forms, and chemical modifications.
    Type: Application
    Filed: November 18, 2016
    Publication date: November 15, 2018
    Inventors: Namritha RAVINDER, Robert Jason POTTER, Jason CARTE
  • CRISPR Oligonucleotides and Gene Editing
    Publication number: 20180195089
    Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
    Type: Application
    Filed: December 14, 2017
    Publication date: July 12, 2018
    Inventors: Namritha RAVINDER, Korbinian HEIL, Yizhu GUO, Xiquan LIANG, Robert POTTER, Sanjay KUMAR
  • CRISPR oligonucleotides and gene editing
    Patent number: 9879283
    Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: January 30, 2018
    Assignees: Life Technologies Corporation, Thermo Fisher Scientific GENEART GmbH
    Inventors: Namritha Ravinder, Korbinian Heil, Yizhu Guo, Xiquan Liang, Robert Potter, Sanjay Kumar
  • COMPOSITIONS AND METHODS FOR ENHANCING HOMOLOGOUS RECOMBINATION
    Publication number: 20180023075
    Abstract: The present disclosure generally relates to compositions and methods for improving the efficiency of homologous recombination. In particular, the disclosure relates to reagents and the use of such reagents.
    Type: Application
    Filed: May 25, 2017
    Publication date: January 25, 2018
    Inventors: Xiquan LIANG, Robert POTTER, Namritha RAVINDER, Shantanu KUMAR
  • CRISPR OLIGONUCLEOTIDES AND GENE EDITING
    Publication number: 20160102322
    Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
    Type: Application
    Filed: October 9, 2015
    Publication date: April 14, 2016
    Inventors: Namritha Ravinder, Korbinian Heil, Yizhu Guo, Xiquan Liang, Robert Potter